GIOSTAR India possesses the capability to address a range of debilitating immunological diseases and blood-related disorders. These encompass conditions such as Diabetes Type I and Type II, Lupus, Multiple Sclerosis, Crohn’s disease, Vasculitis, Scleroderma, Myasthenia Gravis, Sickle Cell Anemia, Leukemia, Lymphoma, Thalassemia. The organization is also actively working on developing therapies for Alzheimer’s, Anti-Aging Treatments, Parkinson’s disease, Cancer, Heart and Retinal Degeneration, Amyotrophic Lateral Sclerosis, Neuropathy, Osteoarthritis, Paralysis, Strokes, Spinal Cord Injuries, Skin Burns, and Spinal Muscular Atrophy (SMA).

GIOSTAR India is currently in the process of establishing Institutes of Regenerative Medicine and dedicated Stem Cell Treatment hospitals/centers across Asia, the Middle East, Africa, North and South America, and Europe. These proposed facilities will be developed with international support from both public and private sectors through grants and investments, aiming to provide stem cell-based therapy for individuals suffering from degenerative or genetic diseases.